In one paragraphArticle in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
José Avendaño-OrtizDepartment of Microbiology, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.ORCID 0000-0003-2774-1821 Alba TribaldoDepartment of Microbiology, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.
Luna BallesteroDepartment of Microbiology, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.
Luis Antonio GómezTranslational Research Group, GAI of Ciudad Real, Research Institute of Castilla-La Mancha (IDISCAM), 13004 Ciudad Real, Spain.
Ignacio GraciaTranslational Research Group, GAI of Ciudad Real, Research Institute of Castilla-La Mancha (IDISCAM), 13004 Ciudad Real, Spain.ORCID 0000-0001-7904-5866 Juan Francisco RodríguezTranslational Research Group, GAI of Ciudad Real, Research Institute of Castilla-La Mancha (IDISCAM), 13004 Ciudad Real, Spain.ORCID 0000-0001-8838-1976 Natalia Bejarano RamírezTranslational Research Group, GAI of Ciudad Real, Research Institute of Castilla-La Mancha (IDISCAM), 13004 Ciudad Real, Spain.ORCID 0000-0001-8605-033X Raquel Bodoque-VillarTranslational Research Group, GAI of Ciudad Real, Research Institute of Castilla-La Mancha (IDISCAM), 13004 Ciudad Real, Spain.ORCID 0000-0002-3827-5582 María Ángeles Vaz-SalgadoMedical Oncology Department, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.
Rosa Del CampoDepartment of Microbiology, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.ORCID 0000-0003-1147-7923 Francisco Javier Redondo-CalvoTranslational Research Group, GAI of Ciudad Real, Research Institute of Castilla-La Mancha (IDISCAM), 13004 Ciudad Real, Spain.ORCID 0000-0002-7044-0154 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
antimicrobialchlorhexidine gluconate (CHG)garlicgrapemethicillin-resistant Staphylococcus aureus (MRSA)Minimum Bactericidal Concentration (MBC)Minimum Inhibitory Concentration (MIC)natural extractpropolisStaphylococcus aureus (S. aureus)
Identifiers
PMID41007713
PMCPMC12467437
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390